3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9 Purity ≥99,0% (HPLC) Favipiravir Intermediate COVID-19
Favipiravir Pasokan Komersial lan Perantara sing Gegandhengan:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8
Jeneng Kimia | 3,6-Dichloropyrazine-2-Carbonitrile |
sinonim | 3,6-Dichloro-2-Pyrazinecarbonitrile;Favipiravir Impurity 18 |
Nomer CAS | 356783-16-9 |
Nomer CAT | RF-PI226 |
Status Simpenan | Ing Simpenan, Skala Produksi Nganti Ton |
Formula Molekul | C5HCl2N3 |
Bobot Molekul | 173.99 |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Kuning pucet nganti bubuk putih |
Identifikasi HPLC | Wektu penylametan puncak utama miturut standar referensi |
Kelembapan (KF) | ≤1,0% |
Sisa ing Ignition | ≤0,30% |
Impurity Tunggal | ≤0,5% |
Total Impurities | ≤1,0% |
Logam abot | ≤20ppm |
Kemurnian | ≥99,0% |
Test Standar | Standar Perusahaan |
Panggunaan | Intermediate Favipiravir (CAS: 259793-96-9) |
Paket: Botol, tas Aluminium foil, Drum Karton, 25kg / Drum, utawa miturut kabutuhan pelanggan.
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya, kelembapan lan infestasi hama.
Shanghai Ruifu Chemical Co., Ltd. minangka produsen lan supplier 3,6-Dichloropyrazine-2-Carbonitrile (CAS: 356783-16-9) kanthi kualitas dhuwur.Ikuminangka perantara biasane ing sintesis 6-Fluoro-3-Hydroxypyrazine-2-Carboxamide kanthi jeneng komersial Favipiravir (CAS: 259793-96-9).
Favipiravir (CAS: 259793-96-9) ing perawatan infeksi virus Influenza.Favipiravir minangka obat antivirus spektrum sing amba sing diresiki dening Pengontrol Obat Umum India (DCGI) minggu kepungkur kanggo panggunaan "diwatesi darurat" ing antarane pasien Covid-19.Glenmark bakal adol favipiravir umum kanthi jeneng merek FabiFlu.Favipiravir wiwitane dikembangake ing pungkasan taun 1990-an dening perusahaan sing banjur dituku dening perusahaan Jepang Fujifilm minangka bagéan saka transisi saka bisnis foto menyang perawatan kesehatan.Sawise dites nglawan macem-macem virus, obat kasebut disetujoni ing Jepang ing taun 2014 kanggo panggunaan darurat nglawan epidemi flu utawa kanggo nambani galur influenza anyar.